OMEROS CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 578.07K shares, a 7855.79% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 1.04M shares, a 5250.84% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 968.60K shares, a 922.75% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 77.68K shares, a 1286.93% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.07M shares, a 865.70% increase from fiscal 2024.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 111.11K shares, a 202.53% increase from fiscal 2023.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 36.73K shares, a 63.70% decline from fiscal 2022.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 101.16K shares, a 89.02% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 578.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 2.66M shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 1.04M shares 10-Q · filed 2026-05-13 | 2.09M shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 968.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 1.07M shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 77.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 199.09K shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 7.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 127.01K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 19.44K shares 10-Q · filed 2025-05-15 | 121.21K shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 94.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 111.11K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 5.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 16.40K shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 1.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 27.97K shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 9.34K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 36.73K shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 17.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 101.16K shares 10-K · filed 2023-03-13 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 176.05K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 227.38K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 101.16K shares 10-Q · filed 2022-05-10 | 466.30K shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 74.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 921.02K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 51.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 852.22K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 238.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 1.04M shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 555.88K shares 10-Q · filed 2021-05-10 | 805.44K shares derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | 6.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 556.42K shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 235.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 836.37K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 8.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 930.50K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-03-31 | 306.86K shares 10-Q · filed 2020-05-11 | 1.10M shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-12-31 | 286.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 799.82K shares 10-K · filed 2020-03-02 |
| 2019-09-30 | 329.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 516.16K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | 173.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 663.49K shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | 10.74K shares 10-Q · filed 2020-05-11 | 701.08K shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | 2.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 765.95K shares 10-K · filed 2019-03-01 |
| 2018-09-30 | 476.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 988.36K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 211.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 1.05M shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 75.62K shares 10-Q · filed 2018-05-10 | 1.35M shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 224.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 1.39M shares 10-K · filed 2018-03-01 |
| 2017-09-30 | 538.84K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 2.08M shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 510.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 1.69M shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | 117.90K shares 10-Q · filed 2017-05-10 | 1.28M shares derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | 908.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 1.49M shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 155.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 648.99K shares derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | 93.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 587.48K shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 329.01K shares 10-Q · filed 2016-05-10 | 537.37K shares derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | 71.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 277.36K shares 10-K · filed 2016-03-15 |
| 2015-09-30 | 93.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 343.87K shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | 43.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 274.78K shares derived: sum of 4 quarters · filed 2015-08-10 |
| 2015-03-31 | 69.00K shares 10-Q · filed 2015-05-11 | 324.22K shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 137.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 297.30K shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 24.41K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 295.31K shares derived: sum of 4 quarters · filed 2014-11-10 |
| 2014-06-30 | 92.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 287.96K shares derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | 42.08K shares 10-Q · filed 2014-05-12 | 214.49K shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | 135.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | 185.32K shares 10-K · filed 2014-03-13 |
| 2013-09-30 | 17.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | 61.66K shares derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-06-30 | 19.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 66.87K shares derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | 12.92K shares 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 12.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 101.39K shares 10-K · filed 2013-03-18 |
| 2012-09-30 | 22.26K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |